News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Digital health
Drug Development
Lilly Makes Weight-Loss Drug Zepbound Available Through Amazon Pharmacy
Eli Lilly has partnered with Amazon Pharmacy to help fill online orders of its obesity drug Zepbound—as well as migraine and diabetes medicines—placed through the pharma’s online portal LillyDirect.
March 13, 2024
·
2 min read
·
Tristan Manalac
PRESS RELEASES
Press Releases
Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to KYZATREX® (testosterone undecanoate) CIII Capsules, the First FDA-Approved Oral Testosterone Therapy Offered on the Hims & Hers Platform
September 11, 2025
·
7 min read
Press Releases
Cumulus Neuroscience Appoints Robert Ballantine to Board of Directors
September 10, 2025
·
3 min read
Press Releases
Stereotaxis Technology to be Featured at Heart Rhythm Society’s HRX 2025
August 29, 2025
·
3 min read
Press Releases
mPATH Partners with NC Health Centers and DHHS to Expand Colorectal Cancer Screening Access Across the State
August 20, 2025
·
5 min read
Press Releases
VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial
June 23, 2025
·
3 min read
Press Releases
NeuralCure AI Launches the First Diagnostic & Digital Twin OS for Preventative Care Clinics
June 19, 2025
·
4 min read
Press Releases
Aptar Digital Health Announces Licensing Agreement With AstraZeneca to Develop AI-Powered Screening Algorithms
May 22, 2025
·
4 min read
Press Releases
WELL Health Announces Approval of Normal Course Issuer Bid
May 15, 2025
·
3 min read
Press Releases
Bipolar Disorder Mood Stabilizers Market to Reach USD 2.64 Billion by 2032, Backed by Advances in Mood Stabilizing Drug Development
May 13, 2025
·
1 min read
Press Releases
RadNet Reports First Quarter Financial Results and Revises Upwards 2025 Financial Guidance Ranges for Revenue and Adjusted EBITDA¹
May 12, 2025
·
31 min read
Press Releases
Sanguina Announces Ruby: The Evolution of AnemoCheck Mobile’s Blood Health Platform
April 8, 2025
·
2 min read
Press Releases
VSee Health Secures $560K Contract to Deploy Virtual Command Center for Major Oncology Network, Strengthening Growth Trajectory in Digital Health Market
February 20, 2025
·
3 min read
Press Releases
Digital Health Market Set to Surge to USD 1,093.65 Billion by 2034 Says Precedence Research
February 11, 2025
·
1 min read
Press Releases
Acellera and Psivant Collaborate to Develop Transformative Computational Drug Discovery Approaches Using AI and Quantum Simulations
January 29, 2025
·
2 min read
Press Releases
Sword Health Acquires Surgery Hero to Accelerate Global Growth and Expand its Presence in the UK
January 24, 2025
·
3 min read
Press Releases
Glooko Secures Reimbursement for Remote Monitoring of Gestational Diabetes in France
January 21, 2025
·
4 min read
UniDoc Health Corp. Reflects on a Year of Growth and Innovation
December 17, 2024
·
7 min read
Press Releases
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 8, 2024
·
1 min read
Press Releases
Baxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors
October 17, 2024
·
1 min read
Press Releases
DATAcc by DiMe Awarded FDA Grant to Boost Use of Sensor-Based Digital Health Technologies in Clinical Trials
October 3, 2024
·
3 min read
